Manufacturer record
Agron Remedies Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Agron Remedies Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between May 2022 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
10 records linked to Agron Remedies Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ondansetron Tablets IP 4 mg | TB251158Mfg 2026-01 · Exp 2027-12 | The sample received does not conform to i.p. 2022, ip addendum 2024 specification with respect to the test for related substances (total impurities) only.Related substances | CDTL, HyderabadCDSCO lab | Jul 2026 |
| Dexamethasone Injection IP 8 mg/ 2 ml | AGDX23Mfg 2025-10 · Exp 2027-03 | The sample does not conforms to the IP with respect to Assay of Dexamethasone Sodium Phosphate eq. to Dexamethasone Phosphate.Assay | DTL JaipurState lab | May 2026 |
| Xylometazoline Hydrochloride Nasal Drops IP | E25057Mfg 2025-07 · Exp 2027-06 | The sample does not conform to IP with respect to test for pH and Uniformity of weight.pH | CDL, KolkataCDSCO lab | Apr 2026 |
| Meropenem Injection IP 250 mg | MRO-05Mfg 2024-08 · Exp 2026-07 | Identification and Assay of Meropenem, Clarity of solution, Particulate Matter, Content of sodium and is also not of standard quality for the reason stated under "Description".Assay | CDL, KolkataCDSCO lab | Jul 2025 |
| Itraconazole Capsules IP 100 mg | CTA-01Mfg 2024-02 · Exp 2026-01 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2025 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg | PGR-02Mfg 2023-12 · Exp 2025-11 | Dissolution in Acid Stage for PantoprazoleDissolution | RDTL GuwahatiCDSCO lab | Jul 2024 |
| Levetiracetam Tablets IP (Levodil-500) | GAG0628Mfg 2023-08 · Exp 2025-07 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jul 2024 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg. | PGR-07Mfg 2024-01 · Exp 2025-12 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jun 2024 |
| Cefuroxime Axetil Tablets IP 500 mg | JAK-20Mfg 2023-05 · Exp 2025-04 | Dissolution and Assay of Cefuroxime Axetil calculated as CefuroximeAssay | RDTL ChandigarhCDSCO lab | Feb 2024 |
| Agrophylline - 2ml (Etophylline & Theophyline for Injection) | AGP-20Mfg 2021-11 · Exp 2023-10 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | May 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.